MedTech News - by Andrew Celentano
A protein that makes hydrogen sulfide shows potential as a therapeutic target for Alzheimer’s disease
Scientists at Johns Hopkins Medicine say results of a new study are advancing efforts to exploit a new target for Alzheimer’s disease: a protein that manufactures an important gas in the brain.
Medtech M&A: The biggest deals of 2025
In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&A) arena.
The top diabetes tech stories of 2025
As the year comes to a close, it’s time to look back at the numerous innovations across the diabetes technology industry in 2025.
AI-powered knowledge graph links heart images to genes and drug predictions
CardioKG provides a detailed view of the heart’s structure and function which dramatically improves the accuracy of predicting which genes are linked to disease and whether existing drugs could treat them.
Breast cancer drug boosts leukemia treatment: Unexpected duo shows promise in overcoming resistance
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common frontline therapies.
Machine learning identifies statin and phenothiazine combo for neuroblastoma treatment
Researchers at Lund University in Sweden have identified a combination of statins and phenothiazines that is particularly promising in the treatment of the aggressive form of neuroblastoma.
Researchers use virtual reality to reduce anxiety about death
Texas A&M University researchers have found that a brief virtual reality (VR) simulation of a near-death experience can sharply reduce people’s anxiety about death. In a small pilot study of about 60 young adults, participants reported a 75% decrease in their fear of death after a single 12-minute session.
Melanoma cancer cells secrete extracellular vesicles to paralyze immune cells
A new international study led by Prof. Carmit Levy of the Department of Human Genetics and Biochemistry at the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds that melanoma cancer cells paralyze immune cells by secreting extracellular vesicles (EVs).